sertraline has been researched along with Cognition Disorders in 36 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 3 (8.33) | 18.2507 |
2000's | 18 (50.00) | 29.6817 |
2010's | 13 (36.11) | 24.3611 |
2020's | 2 (5.56) | 2.80 |
Authors | Studies |
---|---|
Hussain, M; Katyal, J; Rashid, H | 1 |
Krishnamurthy, S; Prajapati, SK | 1 |
Chen, D; Feng, X; Li, T; Li, X; Liu, X; Sun, M; Xu, J; Zhang, Q; Zhang, S; Zhao, X | 1 |
Bruno, G; Canevelli, M; Letteri, F; Tosto, G | 1 |
Barch, DM; D'Angelo, G; Disabato, BM; Doraiswamy, PM; Hranilovich, J; Krishnan, RR; MacFall, JR; Morris, C; Pieper, C; Sheline, YI; Steffens, DC; Taylor, WD; Toffanin, T; Welsh-Bohmer, KA; Wilkins, C | 1 |
Banerjee, S; Bingham, KS; Flint, AJ; Meyers, BS; Mulsant, BH; Rothschild, AJ; Whyte, EM | 1 |
Li, P; Lu, D; Wang, Y; Zhang, HH; Zhou, YY | 1 |
Babyak, MA; Blumenthal, JA; Doraiswamy, PM; Hoffman, BM; Rogers, SD; Sherwood, A; Smith, PJ | 1 |
Arciniegas, DB; McAllister, TW; Silver, JM | 1 |
Allgair, A; Flessner, CA; Foa, E; Franklin, ME; Freeman, J; Garcia, A; March, J; Sapyta, J | 1 |
Kumar, A; Kumar, P | 1 |
Barch, DM; D'Angelo, G; Doraiswamy, PM; Garcia, KS; Gersing, K; Krishnan, RR; MacFall, JR; McKinstry, RC; Pieper, CF; Sheline, YI; Steffens, DC; Taylor, W; Welsh-Boehmer, K; Welsh-Bohmer, K; Wilkins, C | 1 |
Drye, LT; Frangakis, C; Lyketsos, CG; Martin, BK; Meinert, CL; Mintzer, JE; Munro, CA; Porsteinsson, AP; Rabins, PV; Rosenberg, PB; Schneider, LS; Weintraub, D | 1 |
Mori, N; Suda, S; Sugihara, G; Suyama, R; Takei, N | 1 |
Andreasen, JT; Bate, S; Christiansen, S; Henningsen, K; Wiborg, O | 1 |
Barch, DM; Doraiswamy, PM; DʼAngelo, G; Garcia, KS; Gersing, K; Pieper, C; Sheline, YI; Taylor, W; Welsh-Bohmer, K; Wilkins, CH | 1 |
Tobe, E | 1 |
Klasik, A; Krysta, K; Krzystanek, M | 1 |
Blanco, C; Garcia-Toro, M; Gonzalez, A; Gonzalez, E; Saiz-Ruiz, J; Talavera, JA; Tejada, P | 1 |
Camacho, Y; Devanand, DP; Marston, K; Pelton, GH; Roose, SP; Sackeim, HA; Stern, Y | 1 |
Baker, AS; Brandt, J; DelCampo, L; Frangakis, C; Lyketsos, CG; Miles, Q; Munro, C; Rabins, PV; Sheppard, JM; Steele, CD; Steinberg, M | 1 |
Burt, T; Clary, CM; Coffey, DJ; Doraiswamy, PM; Jenkyn, LR; Krishnan, KR; Oxman, T | 1 |
Kumar, SN; Ramanathan, M; Suresh, B | 1 |
Kim, JM; Kim, SW; Lee, H; Shin, IS; Yang, SJ; Yoon, JS | 1 |
Bogetto, F; Calvarese, P; Faggiano, F; Marchiaro, L; Mathis, F; Rivoira, E; Rocca, P; Taricco, B | 1 |
Adam, S; Bruyer, R; Constant, EL; Gillain, B; Seghers, A; Seron, X | 1 |
Berlin, F; Handel, S; Keach, S; Rao, V; Robbins, B; Spiro, J; Vaishnavi, S; Ward, J | 1 |
Alexopoulos, GS; Keilp, JG; Krishnan, KR; Roose, SP; Sackeim, HA; Sneed, JR | 1 |
Devanand, DP; Harper, OL; Pelton, GH; Roose, SP; Sackeim, HA; Scarmeas, N; Tabert, MH | 1 |
Mendez, MF; Shapira, JS | 1 |
Beekman, AT; Comijs, HC; Deeg, DJ; Sonnenberg, CM; van Tilburg, W | 1 |
Oliver, SD; Rapeport, WG; Wesnes, K; Williams, SA | 1 |
Chong, SA; Remington, G | 1 |
Meyers, BS | 1 |
Cohen, CI; Gomberg, D; Kennedy, G; Magai, C | 1 |
Depalma, L; Devivo, MJ; Guin-Renfroe, S; Meythaler, JM; Novack, TA | 1 |
2 review(s) available for sertraline and Cognition Disorders
Article | Year |
---|---|
Depression and cognitive complaints following mild traumatic brain injury.
Topics: Antidepressive Agents, Tricyclic; Brain; Brain Injuries; Central Nervous System Stimulants; Choline; Citalopram; Cognition Disorders; Cognitive Behavioral Therapy; Depression; Humans; Methylphenidate; Neuropsychological Tests; Selective Serotonin Reuptake Inhibitors; Sertraline; Severity of Illness Index | 2009 |
Depression and dementia: comorbidities, identification, and treatment.
Topics: Aged; Aged, 80 and over; Antidepressive Agents, Tricyclic; Benzamides; Citalopram; Clomipramine; Cognition Disorders; Comorbidity; Dementia; Depression; Female; Fluoxetine; Fluvoxamine; Humans; Imipramine; Male; Middle Aged; Moclobemide; Monoamine Oxidase Inhibitors; Neuropsychological Tests; Nortriptyline; Selective Serotonin Reuptake Inhibitors; Sertraline | 1998 |
17 trial(s) available for sertraline and Cognition Disorders
Article | Year |
---|---|
Relationship Between Cerebrovascular Risk, Cognition, and Treatment Outcome in Late-Life Psychotic Depression.
Topics: Adolescent; Adult; Aged; Antidepressive Agents; Antipsychotic Agents; Benzodiazepines; Cerebrovascular Disorders; Cognition; Cognition Disorders; Depressive Disorder, Major; Double-Blind Method; Executive Function; Humans; Mental Processes; Middle Aged; Neuropsychological Tests; Olanzapine; Psychiatric Status Rating Scales; Psychotic Disorders; Reaction Time; Risk; Sertraline; Severity of Illness Index; Stroop Test; Treatment Outcome; Young Adult | 2015 |
Exercise fails to improve neurocognition in depressed middle-aged and older adults.
Topics: Adult; Aged; Aged, 80 and over; Analysis of Variance; Antidepressive Agents; Cognition; Cognition Disorders; Data Interpretation, Statistical; Depressive Disorder, Major; Exercise; Exercise Therapy; Female; Humans; Male; Middle Aged; Neuropsychological Tests; Physical Fitness; Psychometrics; Sedentary Behavior; Sertraline | 2008 |
The impact of neuropsychological functioning on treatment outcome in pediatric obsessive-compulsive disorder.
Topics: Adolescent; Antidepressive Agents, Second-Generation; Child; Cognition Disorders; Cognitive Behavioral Therapy; Combined Modality Therapy; Executive Function; Female; Humans; Male; Mental Recall; Neuropsychological Tests; Obsessive-Compulsive Disorder; Psychomotor Performance; Sertraline; Wechsler Scales | 2010 |
Support for the vascular depression hypothesis in late-life depression: results of a 2-site, prospective, antidepressant treatment trial.
Topics: Age of Onset; Aged; Brain; Cerebrovascular Disorders; Cognition Disorders; Depressive Disorder, Major; Executive Function; Female; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Neuropsychological Tests; Proportional Hazards Models; Prospective Studies; Psychiatric Status Rating Scales; Selective Serotonin Reuptake Inhibitors; Sertraline; Severity of Illness Index; Treatment Outcome | 2010 |
Sertraline for the treatment of depression in Alzheimer disease: week-24 outcomes.
Topics: Activities of Daily Living; Aged; Alzheimer Disease; Antidepressive Agents; Cognition Disorders; Depression; Female; Geriatric Assessment; Humans; Male; Mental Disorders; Patient Compliance; Quality of Life; Sertraline | 2010 |
Cognitive improvement following treatment in late-life depression: relationship to vascular risk and age of onset.
Topics: Age of Onset; Aged; Antidepressive Agents; Cognition Disorders; Depression; Executive Function; Female; Humans; Male; Memory; Mental Status Schedule; Sertraline; Severity of Illness Index; Treatment Outcome; Vascular Diseases | 2012 |
Impact of psychotherapy and antidepressive treatment on cognitive functions in patients treated for depression.
Topics: Antidepressive Agents; Attention; Cognition Disorders; Combined Modality Therapy; Depressive Disorder; Humans; Memory, Short-Term; Neuropsychological Tests; Poland; Psychoanalytic Therapy; Psychometrics; Psychotherapy, Group; Recurrence; Sertraline; Signal Detection, Psychological; Treatment Outcome | 2012 |
Sertraline treatment of elderly patients with depression and cognitive impairment.
Topics: Aged; Aged, 80 and over; Antidepressive Agents; Cognition Disorders; Depressive Disorder; Drug Administration Schedule; Female; Follow-Up Studies; Geriatric Assessment; Humans; Male; Middle Aged; Neuropsychological Tests; Psychiatric Status Rating Scales; Sertraline; Treatment Outcome | 2003 |
Treating depression in Alzheimer disease: efficacy and safety of sertraline therapy, and the benefits of depression reduction: the DIADS.
Topics: Activities of Daily Living; Aged; Alzheimer Disease; Ambulatory Care; Caregivers; Cognition Disorders; Comorbidity; Depressive Disorder; Drug Administration Schedule; Female; Geriatric Assessment; Humans; Male; Mental Disorders; Neuropsychological Tests; Placebos; Psychiatric Status Rating Scales; Selective Serotonin Reuptake Inhibitors; Sertraline; Single-Blind Method; Treatment Outcome | 2003 |
Does antidepressant therapy improve cognition in elderly depressed patients?
Topics: Aged; Aged, 80 and over; Antidepressive Agents; Cognition; Cognition Disorders; Confidence Intervals; Depressive Disorder; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Therapy, Combination; Female; Fluoxetine; Follow-Up Studies; Humans; Male; Middle Aged; Neuropsychological Tests; Nortriptyline; Probability; Reference Values; Sertraline; Severity of Illness Index; Single-Blind Method; Statistics, Nonparametric; Treatment Outcome | 2003 |
Comparing effects of methylphenidate, sertraline and placebo on neuropsychiatric sequelae in patients with traumatic brain injury.
Topics: Adult; Antidepressive Agents; Central Nervous System Stimulants; Cognition Disorders; Depression; Double-Blind Method; Female; Humans; Male; Methylphenidate; Patient Selection; Post-Concussion Syndrome; Prospective Studies; Psychiatric Status Rating Scales; Psychological Tests; Quality of Life; Sertraline; Sleep; Sleep Stages; Treatment Outcome | 2005 |
Citalopram versus sertraline in late-life nonmajor clinically significant depression: a 1-year follow-up clinical trial.
Topics: Age Factors; Aged; Citalopram; Cognition Disorders; Depressive Disorder; Female; Follow-Up Studies; Geriatric Assessment; Humans; Male; Neuropsychological Tests; Psychiatric Status Rating Scales; Research Design; Selective Serotonin Reuptake Inhibitors; Sertraline; Trail Making Test; Treatment Outcome; Wechsler Scales | 2005 |
Response inhibition predicts poor antidepressant treatment response in very old depressed patients.
Topics: Age of Onset; Aged; Antidepressive Agents; Cardiovascular Diseases; Cognition Disorders; Depressive Disorder, Major; Drug Resistance; Female; Humans; Male; Sertraline; Single-Blind Method; Treatment Outcome | 2007 |
Randomized double-blind placebo-controlled donepezil augmentation in antidepressant-treated elderly patients with depression and cognitive impairment: a pilot study.
Topics: Aged; Antidepressive Agents; Cholinesterase Inhibitors; Cognition Disorders; Depressive Disorder; Donepezil; Epidemiologic Methods; Female; Humans; Indans; Male; Middle Aged; Neuropsychological Tests; Nootropic Agents; Piperidines; Sertraline; Treatment Outcome | 2008 |
Absence of effect of sertraline on time-based sensitization of cognitive impairment with haloperidol.
Topics: 1-Naphthylamine; Adolescent; Adult; Cognition; Cognition Disorders; Dose-Response Relationship, Drug; Double-Blind Method; Drug Interactions; Drug Synergism; Haloperidol; Humans; Male; Middle Aged; Placebos; Psychological Tests; Psychomotor Performance; Reaction Time; Selective Serotonin Reuptake Inhibitors; Sertraline | 1996 |
A controlled clinical trial of sertraline in the treatment of depression in nursing home patients with late-stage Alzheimer's disease.
Topics: Aged; Aged, 80 and over; Alzheimer Disease; Antidepressive Agents; Cognition Disorders; Depressive Disorder; Dose-Response Relationship, Drug; Double-Blind Method; Female; Humans; Neuropsychological Tests; Nursing Homes; Sertraline; Severity of Illness Index | 2000 |
Sertraline to improve arousal and alertness in severe traumatic brain injury secondary to motor vehicle crashes.
Topics: Accidents, Traffic; Adolescent; Adult; Aged; Arousal; Brain Injuries; Cognition Disorders; Female; Humans; Male; Middle Aged; Placebos; Selective Serotonin Reuptake Inhibitors; Sertraline; Severity of Illness Index | 2001 |
17 other study(ies) available for sertraline and Cognition Disorders
Article | Year |
---|---|
Response to sertraline and antiepileptic drugs in pentylenetetrazole kindling in rats.
Topics: Animals; Anticonvulsants; Avoidance Learning; Cognition Disorders; Convulsants; Glutathione; Kindling, Neurologic; Levetiracetam; Male; Maze Learning; Oxidative Stress; Pentylenetetrazole; Rats; Rats, Wistar; Seizures; Selective Serotonin Reuptake Inhibitors; Sertraline; Valproic Acid | 2021 |
Development and treatment of cognitive inflexibility in sub-chronic stress-re-stress (SRS) model of PTSD.
Topics: Acetylcholine; Animals; Cholinesterase Inhibitors; Cognition Disorders; Disease Models, Animal; Donepezil; Hippocampus; Male; Prefrontal Cortex; Rats; Rats, Wistar; Selective Serotonin Reuptake Inhibitors; Sertraline; Stress Disorders, Post-Traumatic | 2021 |
Reversal of reserpine-induced depression and cognitive disorder in zebrafish by sertraline and Traditional Chinese Medicine (TCM).
Topics: Adrenergic Uptake Inhibitors; Animals; Antidepressive Agents; Cognition Disorders; Depression; Drugs, Chinese Herbal; Locomotion; Medicine, Chinese Traditional; Reserpine; Selective Serotonin Reuptake Inhibitors; Sertraline; Zebrafish | 2018 |
Efficacy of sertraline in a patient with Neuro-Beçhet's disease.
Topics: Aged; Behcet Syndrome; Cognition Disorders; Humans; Male; Neuropsychological Tests; Selective Serotonin Reuptake Inhibitors; Sertraline | 2013 |
Treatment course with antidepressant therapy in late-life depression.
Topics: Aged; Amygdala; Antidepressive Agents; Brain; Caudate Nucleus; Cerebral Cortex; Cognition Disorders; Depressive Disorder, Major; Female; Frontal Lobe; Hippocampus; Humans; Image Interpretation, Computer-Assisted; Magnetic Resonance Imaging; Male; Middle Aged; Neural Pathways; Neuropsychological Tests; Organ Size; Parahippocampal Gyrus; Personality Inventory; Prospective Studies; Psychometrics; Reaction Time; Sertraline; Treatment Outcome | 2012 |
Correlated patterns of neuropsychological and behavioral symptoms in frontal variant of Alzheimer disease and behavioral variant frontotemporal dementia: a comparative case study.
Topics: Aged; Alzheimer Disease; Behavioral Symptoms; Cognition Disorders; Female; Follow-Up Studies; Frontal Lobe; Frontotemporal Dementia; Humans; Middle Aged; Neuroimaging; Neuropsychological Tests; Selective Serotonin Reuptake Inhibitors; Sertraline | 2016 |
Protective role of sertraline against 3-nitropropionic acid-induced cognitive dysfunction and redox ratio in striatum, cortex and hippocampus of rat brain.
Topics: Acetylcholinesterase; Animals; Antidepressive Agents; Antihypertensive Agents; Behavior, Animal; Brain; Cerebral Cortex; Cognition Disorders; Corpus Striatum; Glutathione; Hippocampus; Male; Maze Learning; Neurotoxins; Nitro Compounds; Oxidation-Reduction; Oxidative Stress; Propionates; Rats; Rats, Wistar; Sertraline | 2009 |
Donepezil and concurrent sertraline treatment is associated with increased hippocampal volume in a patient with depression.
Topics: Adult; Alzheimer Disease; Atrophy; Cholinesterase Inhibitors; Cognition Disorders; Depressive Disorder, Major; Diagnosis, Differential; Donepezil; Drug Therapy, Combination; Female; Follow-Up Studies; Functional Laterality; Hippocampus; Humans; Indans; Magnetic Resonance Imaging; Piperidines; Selective Serotonin Reuptake Inhibitors; Sertraline; Treatment Outcome | 2010 |
Nicotine reverses anhedonic-like response and cognitive impairment in the rat chronic mild stress model of depression: comparison with sertraline.
Topics: Anhedonia; Animals; Antidepressive Agents; Behavior, Animal; Cognition Disorders; Depression; Disease Models, Animal; Drug Therapy, Combination; Male; Nicotine; Nicotinic Agonists; Rats; Rats, Wistar; Sertraline; Stress, Psychological; Sucrose | 2011 |
Progressive neuropsychiatric and brain abnormalities after smoke inhalation.
Topics: Activities of Daily Living; Brain; Cognition Disorders; Depressive Disorder, Major; DNA Damage; Fluorodeoxyglucose F18; Fructose; Humans; Male; Memory, Long-Term; Methylphenidate; Middle Aged; Neurodegenerative Diseases; Neuropsychological Tests; Oxidative Stress; Positron-Emission Tomography; Radiopharmaceuticals; Sertraline; Smoke Inhalation Injury; Time Factors; Topiramate; Valproic Acid | 2012 |
Audioverbal cognitive dysfunction in depression. Factors involved.
Topics: Adolescent; Adult; Antidepressive Agents; Antidepressive Agents, Tricyclic; Attention; Cognition Disorders; Depression; Female; Humans; Imipramine; Male; Memory Disorders; Middle Aged; Reaction Time; Sertraline; Severity of Illness Index; Task Performance and Analysis | 2003 |
Evaluation of cognitive function of fluoxetine, sertraline and tianeptine in isolation and chronic unpredictable mild stress-induced depressive Wistar rats.
Topics: Animals; Antidepressive Agents; Behavior, Animal; Cognition Disorders; Depression; Female; Fluoxetine; Male; Rats; Rats, Wistar; Sertraline; Stress, Physiological; Thiazepines | 2003 |
Effects of sertraline on depressive symptoms and attentional and executive functions in major depression.
Topics: Adult; Aged; Attention; Cognition Disorders; Depressive Disorder, Major; Diagnostic and Statistical Manual of Mental Disorders; Female; Humans; Male; Middle Aged; Neuropsychological Tests; Psychomotor Performance; Reaction Time; Selective Serotonin Reuptake Inhibitors; Sertraline; Surveys and Questionnaires; Thyroid Function Tests | 2005 |
Psychiatric sequelae of traumatic brain injury: a case report.
Topics: Adult; Amantadine; Brain Injuries; Clinical Protocols; Cognition Disorders; Cognitive Behavioral Therapy; Combined Modality Therapy; Depressive Disorder, Major; Humans; Male; Mental Disorders; Psychotherapy; Selective Serotonin Reuptake Inhibitors; Sertraline | 2007 |
The spectrum of recurrent thoughts and behaviors in frontotemporal dementia.
Topics: Aged; Antipsychotic Agents; Basal Ganglia; Cognition Disorders; Dementia; Dibenzothiazepines; Dopamine Agents; Female; Humans; Magnetic Resonance Imaging; Memantine; Neuropsychological Tests; Quetiapine Fumarate; Recurrence; Sertraline; Stereotypic Movement Disorder; Thinking | 2008 |
Trends in antidepressant use in the older population: results from the LASA-study over a period of 10 years.
Topics: Adult; Age Distribution; Age Factors; Aged; Antidepressive Agents; Citalopram; Cognition Disorders; Comorbidity; Depressive Disorder; Depressive Disorder, Major; Disability Evaluation; Drug Utilization; Geriatric Assessment; Humans; Longitudinal Studies; Middle Aged; Multivariate Analysis; Netherlands; Selective Serotonin Reuptake Inhibitors; Sertraline; Severity of Illness Index; Treatment Outcome | 2008 |
Re: Sertraline-clozapine interaction.
Topics: Clozapine; Cognition Disorders; Drug Therapy, Combination; Humans; Selective Serotonin Reuptake Inhibitors; Serotonin Receptor Agonists; Sertraline | 1998 |